Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8461188 | 0.83 | ALDH1A1 (0.35) | ALDH1A1 | |
| Chloromethane SCHEMBL28843809 | 0.81 | — | — | |
| SCHEMBL1153 | 0.80 | — | — | |
| SCHEMBL11615697 | 0.80 | — | — | |
| SCHEMBL5306546 | 0.80 | LMNA (0.31) | — | |
| Methane SCHEMBL8083282 | 0.80 | ALDH1A1 (0.33) | ALDH1A1 | |
| Tert-Butanol SCHEMBL9765186 | 0.79 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL8977760 | 0.78 | ALDH1A1 (0.32) | ALDH1A1 | |
| Water SCHEMBL5322619 | 0.76 | — | — | |
| SCHEMBL3473432 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4375333-A1 | POLYIMIDE COATING MATERIAL | PI Advanced Materials Co., Ltd. (KR) | 2024-05-29 | — | — | EP | disclosed |
| EP-4375332-A1 | POLYAMIC ACID COMPOSITION AND POLYIMIDE COATING MATERIAL COMPRISING SAME | PI Advanced Materials Co., Ltd. (KR) | 2024-05-29 | — | — | EP | disclosed |
| CN-117677673-A | Polyamic acid composition and polyimide cover comprising same | PI尖端素材株式会社 | 2024-03-08 | — | — | CN | disclosed |
| CN-117651739-A | Polyimide cover | PI尖端素材株式会社 | 2024-03-05 | — | — | CN | disclosed |
| US-20240018307-A1 | POLYAMIC ACID COMPOSITION, AND POLYIMIDE COMPRISING SAME | PI ADVANCED MATERIALS CO., LTD. (KR) | 2024-01-18 | — | — | US | disclosed |
| US-20240002601-A1 | POLYAMIC ACID COMPOSITION, AND POLYIMIDE COMPRISING SAME | PI ADVANCED MATERIALS CO., LTD. (KR) | 2024-01-04 | — | — | US | disclosed |
| US-20240002600-A1 | POLYAMIC ACID COMPOSITION, AND POLYIMIDE COMPRISING SAME | PI ADVANCED MATERIALS CO., LTD. (KR) | 2024-01-04 | — | — | US | disclosed |
| US-20230416464-A1 | POLYAMIC ACID COMPOSITION, AND POLYIMIDE COMPRISING SAME | PI ADVANCED MATERIALS CO., LTD. (KR) | 2023-12-28 | — | — | US | disclosed |
| US-20230416465-A1 | POLYAMIC ACID COMPOSITION, AND POLYIMIDE COMPRISING SAME | PI ADVANCED MATERIALS CO., LTD. (KR) | 2023-12-28 | — | — | US | disclosed |
| US-7968707-B2 | Reacting an amino, hydroxy substituted amide with a heterocyclic substituted carboxylic acid to produce (2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl) amino-3-hydroxy-5-[2S-1-imidazolidin-2-onyl)-3-methyl-butanoyl] amino-1,6-diphenylhexane; inhibitors of HIV infection | ABBOTT LABORATORIES (US) | 2011-06-28 | — | — | US | disclosed |
| US-20080139811-A1 | RETROVIRAL PROTEASE INHIBITING COMPOUNDS | ABBVIE INC. | 2008-06-12 | — | — | US | disclosed |
| EP-0538348-B1 | UNSATURATED 15-DEHYDRO-17alpha-CYANOMETHYL-17beta- HYDROXYSTEROIDS | JENAPHARM GMBH (DE) | 1996-10-02 | — | — | EP | disclosed |
| US-5438134-A | Endocrine disorders, reproductive control | JENAPHARM GMBH (DE) | 1995-08-01 | — | — | US | disclosed |
| EP-0538348-A1 | PROCESS FOR PRODUCING UNSATURATED 17-ALPHA-CYANOMETHYL-17-BETA-HYDROXYSTEROIDS. | JENAPHARM GMBH (DE) | 1993-04-28 | — | — | EP | disclosed |
| WO-1992000991-A1 | PROCESS FOR PRODUCING UNSATURATED 17-ALPHA-CYANOMETHYL-17-BETA-HYDROXYSTEROIDS | JENAPHARM GMBH (DE) | 1992-01-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080139811-A1 | RETROVIRAL PROTEASE INHIBITING COMPOUNDS | SERPINB1, PREP, DNPEP | ALDH1A1 3021/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.